EFFICACY OF ADJUVANT VERSUS NEOADJUVANT CHEMOTHERAPY IN HISPANIC/LATINO WOMEN WITH EARLY STAGE, TRIPLE NEGATIVE BREAST CANCER (TNBC)

被引：0
|
作者：
Philipovskiy, A. [1 ]
Corral, J. [1 ]
Heydariana, R. [1 ]
Gaur, S. [1 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, El Paso, TX USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2019年 / 67卷 / 02期
关键词：
D O I：
10.1136/jim-2018-000974.611
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
605
引用
收藏
页码：593 / 593
页数：1
相关论文
共 50 条
  • [31] Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
    Tian, Hao
    Ma, Dandan
    Tan, Xuanni
    Yan, Wenting
    Wu, Xiujuan
    He, Cheng
    Zhong, Ling
    Zhang, Yan
    Yu, Bingjie
    Zhang, Yi
    Qi, Xiaowei
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [32] Neoadjuvant or adjuvant chemotherapy in early breast cancer?
    Montemurro, Filippo
    Nuzzolese, Imperia
    Ponzone, Riccardo
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (09) : 1071 - 1082
  • [33] Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
    Feng Ding
    Ru-Yue Chen
    Jun Hou
    Jing Guo
    Tian-Yi Dong
    World Journal of Clinical Cases, 2022, 10 (12) : 3698 - 3708
  • [34] Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
    Ding, Feng
    Chen, Ru-Yue
    Hou, Jun
    Guo, Jing
    Dong, Tian-Yi
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (12) : 3698 - 3708
  • [35] Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node Negative T1 Triple Negative Breast Cancer
    Huang, Kai
    Jakub, James
    Gabriel, Emmanuel
    Moreno-Aspitia, Alvaro
    McLaughlin, Sarah
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (12) : 7026 - 7035
  • [36] Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node Negative T1 Triple Negative Breast Cancer
    Kai Huang
    James Jakub
    Emmanuel Gabriel
    Alvaro Moreno-Aspitia
    Sarah McLaughlin
    Annals of Surgical Oncology, 2023, 30 : 7026 - 7035
  • [37] Neoadjuvant chemotherapy with dose-dense doxorubicin, cisplatin, and paclitaxel in patients with early triple-negative breast cancer (TNBC).
    Frolova, Mona
    Ignatova, Ekaterina
    Glazkova, Elena
    Petrovsky, Alexander
    Tjulandin, Sergei
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [38] Trends, patterns, and outcomes of neoadjuvant chemotherapy (NACT) use among patients with early invasive triple negative breast cancer (TNBC)
    Jackson, Inimfon
    Lei, Xiudong
    Malinowski, Catalina
    Giordano, Sharon H.
    Chavez-MacGregor, Mariana
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] Outcomes of neoadjuvant (NA) and adjuvant (A) chemotherapy in geriatric patients with stage I-III triple-negative breast cancer (TNBC): A single institution experience.
    Sam, Christine
    Sehovic, Marina
    Extermann, Martine
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [40] Clinical and pathological response to neoadjuvant chemotherapy (NCT) in patients with triple-negative breast cancer (TNBC).
    Krivorotko, Petr
    Zhiltsova, Elena
    Gigolaeva, Larisa
    Emelyanov, Alexander
    Pesotskiy, Roman
    Yerechshenko, Sergey
    Nikolaev, Kirill
    Komyahov, Alexander
    Ivanova, Olga
    Tabagua, Tengiz
    Zernov, Konstantin
    Ivanov, Vadim
    Aseeva, Zalina
    Bessonov, Alexander
    Semiglazov, Vladimir
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345